TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biobank AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 19,687 | 16,657 | 16,402 |
Financial expenses | 60 | 68 | 87 |
Earnings before taxes | 2,273 | 1,804 | 2,267 |
Total assets | 13,884 | 11,117 | 9,262 |
Current assets | 10,723 | 7,248 | 5,686 |
Current liabilities | 2,612 | 2,093 | 1,834 |
Equity capital | 7,772 | 5,785 | 5,535 |
- share capital | 317 | 307 | 300 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 56.0% | 52.0% | 59.8% |
Turnover per employee | |||
Profit as a percentage of turnover | 11.5% | 10.8% | 13.8% |
Return on assets (ROA) | 16.8% | 16.8% | 25.4% |
Current ratio | 410.5% | 346.3% | 310.0% |
Return on equity (ROE) | 29.2% | 31.2% | 41.0% |
Change turnover | 2,487 | -130 | 6,087 |
Change turnover % | 14% | -1% | 59% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.